Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Who chooses when an operation is worth having?
| The first 150 words of the full text of this article appear below. |
EDITOR
In view of the many excellent publications recently in the
BMJ on the need to involve consumers in decisions about treatment and screening,1 I am concerned that Urban's
editorial on ovarian cancer includes the statement: "Five operations
for each cancer found is an acceptable surgery to malignancy
ratio."2
To whom is five operations to find one cancer an acceptable ratio?
Women? Health authorities? Surgeons? Radiologists? Surely it is time to
abandon this paternalistic and rigid approach of prescribing what is or
is not an acceptable trade-off of benefits and risks and then
implementing that for everyone. Consumers should be given the
opportunity to decide whether, for them, the benefit is worth
the risk. For those of us in the health business, our role should
be to support consumers in their decision making rather than to
make judgments for everyone.
| 1. |
Austoker J.
Gaining informed consent for screening.
BMJ
1999;
319:
722-723 |
| 2. |
Urban N.
Screening for ovarian cancer.
BMJ
1999;
319:
1317-1318 |
Mass screening may not prove to be sound public health policy
EDITOR
Urban persuasively makes the scientific case for